Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

SHE:002262 Revenue

Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.56B CNY in the quarter ending September 30, 2026, with 6.61% growth. This brings the company's total for the last twelve months to 6.22B, up 3.20% year-over-year. In the year 2025, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.91B with 3.75% growth. That makes Jiangsu Nhwa Pharmaceutical Co., LTD the 7,948th largest company in the world by revenue and 1,198th in China.

• Revenue (ttm): 6.22B
• Revenue Growth: +3.20%
• P/S Ratio: 3.52
• Revenue / Employee: 1.04M
• Employees: 6,003
• Market Cap: 21.89B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Manufacturing 4.99B 82.8%
• Commercial 888.77M 14.8%
• Others 144.21M 2.4%

By Geography

Chart

• China 5.85B 99.0%
• Unallocated 35.12M 0.6%
• Foreign 23.30M 0.4%

Fiscal year ended Dec 31, 2025 See the full SHE:002262 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.91B	213.56M	3.75%
Dec 31, 2024	5.70B	656.13M	13.01%
Dec 31, 2023	5.04B	742.99M	17.28%
Jan 1, 2023	4.30B	362.85M	9.22%
Jan 1, 2022	3.94B	574.36M	17.09%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error